Gsk (GSK) Cash & Current Investments (2009 - 2026)
Gsk (GSK) reported Cash & Current Investments of $3.92 billion for the quarter ended Sep 30, 2026, down 11.8% from $4.44 billion a year earlier and down 4.8% from the prior quarter.
Gsk (GSK) Cash & Current Investments (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk posted Cash & Current Investments of $4.59 billion, down 6.1% from the prior year.
- Cash & Current Investments has a five-year compound annual growth rate of -12.0% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Current Investments came in at $4.88 billion in the year ended Dec 31, 2024 (+28.8%), $3.79 billion in the year ended Dec 31, 2023 (-17.0%), $4.57 billion in the year ended Dec 31, 2022 (-21.9%) and $5.85 billion in the year ended Dec 31, 2021 (-32.6%).
- The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Cash & Current Investments since the quarter ended Jun 30, 2024.
- Year over year, Cash & Current Investments has now declined in each of the last four quarters, with growth averaging 8.8% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was the quarter ended Mar 31, 2023 (growth of 627.4%); the low point was the quarter ended Mar 31, 2022 (a decline of 92.4%).
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at $4.12 billion (quarter ended Jun 30, 2026), $4.54 billion (quarter ended Mar 31, 2026) and $4.59 billion (quarter ended Dec 31, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 3.92 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.92 Bn |
| Jun 30, 2026 | 4.12 Bn |
| Mar 31, 2026 | 4.54 Bn |
| Dec 31, 2025 | 4.59 Bn |
| Sep 30, 2025 | 4.44 Bn |
| Jun 30, 2025 | 4.97 Bn |
| Mar 31, 2025 | 5.80 Bn |
| Dec 31, 2024 | 4.88 Bn |
| Sep 30, 2024 | 4.30 Bn |
| Jun 30, 2024 | 3.77 Bn |
| Mar 31, 2024 | 3.55 Bn |
| Dec 31, 2023 | 3.79 Bn |
| Sep 30, 2023 | 3.96 Bn |
| Jun 30, 2023 | 4.10 Bn |
| Mar 31, 2023 | 3.66 Bn |
| Dec 31, 2022 | 4.57 Bn |
| Sep 30, 2022 | 4.11 Bn |
| Jun 30, 2022 | 7.92 Bn |
| Mar 31, 2022 | 503.22 Mn |
| Dec 31, 2021 | 5.85 Bn |
Gsk Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();